Picture Kentro Design Is Key to Your Success Berlin 650x100px

Organisation › Details

Bill and Melinda Gates Medical Research Institute

	Start	2019-04-25 existent
	Group	GATES Group (family of Bill Gates)
	Industry	medicine

	City	n. a.
		Address record changed: 2019-05-12

Basic data	Employees	n. a.


		Record changed: 2023-03-06

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for GATES Group (family of Bill Gates)

[1] Transimmune AG. (9/20/23). "Press Release: Transimmune Secures $5m Funding to Enhance mRNA Vaccination with Novel Dendritic Cell Therapy". Düsseldorf....
[2] Cerevance. (2/23/23). "Press Release: Cerevance Expands Series B Financing with Additional $51 Million". Boston, MA....
[3] MedinCell S.A.. (11/30/22). "Press Release: Additional US$ 4 Million Received for Next Development Steps of MedinCell’s 6-month Active Injectable Bioresorbable Subcutaneous Contraceptive". Montpellier....
[4] Touchlight Genetics Ltd.. (11/29/22). "Press Release: Touchlight Receives Grant to Advance Rapid, Scalable and Thermostable doggybone DNA Vaccine Platform". Hampton....
[5] Nuvisan ICB GmbH. (9/20/22). "Press Release: Nuvisan Receives US$ 9.6m Grant for a Multi-target Drug Discovery Program on Novel Non-hormonal Contraceptive Medicines". Berlin....
[6] Eleven Therapeutics. (8/2/22). "Press Release: Eleven Therapeutics Announces $22 Million in Seed Funding. Round Includes $9 Million from the Bill & Melinda Gates Foundation". Tel Aviv & Cambridge....
[7] Evotec SE. (12/16/21). "Press Release: Evotec Receives US$ 18 m Grant for Women’s Health". Hamburg....
[8] Biotalys N.V.. (10/20/21). "Press Release: Biotalys Awarded Multi-Year Grant to Develop New Biological Solutions for Cowpea and Other Legumes". Ghent & Research Triangle Park, NC....
[9] Exscientia Ltd.. (9/8/21). "Press Release: Exscientia Enters $70M Collaboration to Develop Anti-viral Therapeutics against Coronavirus and other Viruses with Pandemic Potential"....
[10] Exscientia Ltd.. (7/8/21). "Press Release: Exscientia Accelerates COVID-19 Drug Discovery Using AI". Oxford....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]